Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)
Titel:
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)
Auteur:
Tahara, M. Kiyota, N. Yokota, T. Hasegawa, Y. Muro, K. Takahashi, S. Onoe, T. Homma, A. Taguchi, J. Suzuki, M. Minato, K. Yane, K. Ueda, S. Hara, H. Saijo, K. Yamanaka, T.